Close Menu

Delaware Biotechnology Institute

Little State, Big Dreams

Premium

The Delaware Biotechnology Institute was started with economic development in mind, but the scientists who call it home say it's been a significant boon to their own research.

William Moffitt signed a three-year contract to remain president and CEO of Nanosphere, while BioTrove's Al Luderer joined Agendia's supervisory board, and more.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.